Qingxi Huang serves as Executive at US-China Biomedical Technology, Inc., where they oversee executive responsibilities. Since joining the company, Qingxi Huang has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 29, 2019 involved purchasing 4,290,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 29, 2019 | UCBB | $0 | Purchase | 4,290,000 | $N/A | Discretionary |
Qingxi Huang currently holds 12,422,000 shares of US-China Biomedical Technology, Inc. (UCBB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Qingxi Huang has been a net neutral trader of UCBB stock. They have purchased $0 and sold $0 worth of shares.
Qingxi Huang's most recent insider trade was on May 29, 2019, when they purchased 4,290,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted